SCHEMBL30009812

SCHEMBL30009812

[2H]c1c(Cl)[nH]c2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
KDM4E B2RXH2 4/20 0.41
MAPT P10636 3/20 0.41
HPGD P15428 2/20 0.41
MEN1 O00255 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
CASP3 P42574 1/20 0.41
KMT2A Q03164 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
AOC3 Q16853 2/20 0.40
CA1 P00915 2/20 0.40
CA4 P22748 2/20 0.40
CA6 P23280 2/20 0.40
CA12 O43570 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL980499 0.76 AOC3 (0.54) ALDH1A1NPC1RAB9AKDM4EMAPT
SCHEMBL30041175 0.76 AOC3 (0.54) ALDH1A1NPC1RAB9AKDM4EMAPT
Methane SCHEMBL27716118 0.74 AOC3 (0.52) ALDH1A1NPC1RAB9AKDM4EMAPT
SCHEMBL12003943 0.74 AOC3 (0.52) ALDH1A1NPC1RAB9AKDM4EMAPT
SCHEMBL30010158 0.73 ALDH1A1 (0.45) ALDH1A1NPC1RAB9AKDM4EMAPT
2-Phenyl-1H-Indole SCHEMBL29581436 0.70 NPC1 (0.64) ALDH1A1NPC1RAB9AKDM4EMAPT
SCHEMBL29139308 0.70 KDM4E (0.47) ALDH1A1NPC1RAB9AKDM4EMAPT
SCHEMBL27556311 0.67 DAO (0.47) ALDH1A1NPC1RAB9AKDM4EMAPT
Phosphoric Acid SCHEMBL18344261 0.67 FLT3 (0.48) ALDH1A1NPC1RAB9AKDM4EMAPT
SCHEMBL31465196 0.66 TUBB4A (0.37) ALDH1A1NPC1RAB9AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260124174-A1 COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS ATAI THERAPEUTICS INC (US) 2026-05-07 US disclosed
US-20260115168-A1 COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS ATAI THERAPEUTICS INC (US) 2026-04-30 US disclosed
US-20260115167-A1 NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS ATAI THERAPEUTICS INC (US) 2026-04-30 US disclosed
US-12472163-B2 Compositions of matter and pharmaceutical compositions ATAI THERAPEUTICS, INC. (US) 2025-11-18 US disclosed
US-12396982-B2 Compositions of matter and pharmaceutical compositions ATAI THERAPEUTICS, INC. (US) 2025-08-26 US disclosed
US-20250235428-A1 NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS PSILERA INC. 2025-07-24 US disclosed
US-20250064783-A1 Compositions of Matter and Pharmaceutical Compositions PSILERA INC. 2025-02-27 US disclosed
US-20250041273-A1 NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS ATAI LIFE SCIENCES N.V. (DE) 2025-02-06 US disclosed
US-12053453-B2 Compositions of matter and pharmaceutical compositions PSILERA INC. (US) 2024-08-06 US disclosed
US-20230372295-A1 NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS ATAI THERAPEUTICS, INC. 2023-11-23 US disclosed
US-11759452-B2 Compositions of matter and pharmaceutical compositions PSILERA INC. (US) 2023-09-19 US disclosed
US-20220354824-A1 NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS ATAI THERAPEUTICS, INC. 2022-11-10 US disclosed
US-11478449-B1 Compositions of matter and pharmaceutical compositions PSILERA INC. (US) 2022-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260115168-A1 COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS PNMT, HTR5A, TPH2 ALDH1A1 3346/4885NPC1 467/4885RAB9A 1114/4885
US-20250235428-A1 NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS TPH1, HTR2C, HTR1B ALDH1A1 3556/4885NPC1 797/4885RAB9A 2152/4885
US-11478449-B1 Compositions of matter and pharmaceutical compositions TPH1, HTR1B, HTR2C ALDH1A1 3634/4885NPC1 511/4885RAB9A 2004/4885
US-20250064783-A1 Compositions of Matter and Pharmaceutical Compositions TPH1, HTR1B, HTR2C ALDH1A1 3634/4885NPC1 511/4885RAB9A 2004/4885
US-12472163-B2 Compositions of matter and pharmaceutical compositions TPH1, HTR1B, HTR2C ALDH1A1 3634/4885NPC1 511/4885RAB9A 2004/4885
US-20260115167-A1 NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS HTR2C, HTR5A, TPH2 ALDH1A1 3719/4885NPC1 860/4885RAB9A 1285/4885
US-20250041273-A1 NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS TPH1, HTR2C, HTR1B ALDH1A1 3556/4885NPC1 797/4885RAB9A 2152/4885
US-20230372295-A1 NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS TPH1, HTR2C, HTR1B ALDH1A1 3556/4885NPC1 797/4885RAB9A 2152/4885
US-20220354824-A1 NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS TPH1, HTR2C, HTR1B ALDH1A1 3556/4885NPC1 797/4885RAB9A 2152/4885
US-11759452-B2 Compositions of matter and pharmaceutical compositions TPH1, HTR1B, HTR2C ALDH1A1 3634/4885NPC1 511/4885RAB9A 2004/4885
US-20260124174-A1 COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS MAOB, TPH1, TPH2 ALDH1A1 1586/4885NPC1 262/4885RAB9A 2243/4885
US-12053453-B2 Compositions of matter and pharmaceutical compositions TPH1, HTR1B, HTR2C ALDH1A1 3634/4885NPC1 511/4885RAB9A 2004/4885
US-12396982-B2 Compositions of matter and pharmaceutical compositions TPH1, HTR1B, HTR2C ALDH1A1 3634/4885NPC1 511/4885RAB9A 2004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.